These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32255049)
1. Targeted and NIR light-controlled delivery of nitric oxide combined with a platinum(iv) prodrug for enhanced anticancer therapy. Shi SW; Li YH; Zhang QL; Yang SP; Liu JG J Mater Chem B; 2019 Mar; 7(11):1867-1874. PubMed ID: 32255049 [TBL] [Abstract][Full Text] [Related]
2. A ruthenium-nitrosyl-functionalized nanoplatform for the targeting of liver cancer cells and NIR-light-controlled delivery of nitric oxide combined with photothermal therapy. Li YH; Guo M; Shi SW; Zhang QL; Yang SP; Liu JG J Mater Chem B; 2017 Oct; 5(38):7831-7838. PubMed ID: 32264384 [TBL] [Abstract][Full Text] [Related]
3. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy. Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670 [TBL] [Abstract][Full Text] [Related]
4. Ruthenium nitrosyl grafted carbon dots as a fluorescence-trackable nanoplatform for visible light-controlled nitric oxide release and targeted intracellular delivery. Deng Q; Xiang HJ; Tang WW; An L; Yang SP; Zhang QL; Liu JG J Inorg Biochem; 2016 Dec; 165():152-158. PubMed ID: 27324826 [TBL] [Abstract][Full Text] [Related]
5. A Ruthenium Nitrosyl-Functionalized Magnetic Nanoplatform with Near-Infrared Light-Controlled Nitric Oxide Delivery and Photothermal Effect for Enhanced Antitumor and Antibacterial Therapy. Yu YT; Shi SW; Wang Y; Zhang QL; Gao SH; Yang SP; Liu JG ACS Appl Mater Interfaces; 2020 Jan; 12(1):312-321. PubMed ID: 31840976 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells. Braga CB; Perli G; Becher TB; Ornelas C Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218 [TBL] [Abstract][Full Text] [Related]
7. Folate-decorated and NIR-activated nanoparticles based on platinum(IV) prodrugs for targeted therapy of ovarian cancer. Sun Y; Shi T; Zhou L; Zhou Y; Sun B; Liu X J Microencapsul; 2017 Nov; 34(7):675-686. PubMed ID: 29027828 [TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and Characterization of Nitric Oxide-Releasing Platinum(IV) Prodrug and Polymeric Micelle Triggered by Light. Pramanick S; Kim J; Kim J; Saravanakumar G; Park D; Kim WJ Bioconjug Chem; 2018 Apr; 29(4):885-897. PubMed ID: 29281788 [TBL] [Abstract][Full Text] [Related]
10. A theranostic prodrug delivery system based on Pt(IV) conjugated nano-graphene oxide with synergistic effect to enhance the therapeutic efficacy of Pt drug. Li J; Lyv Z; Li Y; Liu H; Wang J; Zhan W; Chen H; Chen H; Li X Biomaterials; 2015 May; 51():12-21. PubMed ID: 25770993 [TBL] [Abstract][Full Text] [Related]
11. Ruthenium nitrosyl functionalized graphene quantum dots as an efficient nanoplatform for NIR-light-controlled and mitochondria-targeted delivery of nitric oxide combined with photothermal therapy. Guo M; Xiang HJ; Wang Y; Zhang QL; An L; Yang SP; Ma Y; Wang Y; Liu JG Chem Commun (Camb); 2017 Mar; 53(22):3253-3256. PubMed ID: 28261712 [TBL] [Abstract][Full Text] [Related]
12. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug. Shanmugam V; Chien YH; Cheng YS; Liu TY; Huang CC; Su CH; Chen YS; Kumar U; Hsu HF; Yeh CS ACS Appl Mater Interfaces; 2014 Mar; 6(6):4382-93. PubMed ID: 24559392 [TBL] [Abstract][Full Text] [Related]
13. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI. Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364 [TBL] [Abstract][Full Text] [Related]
14. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy. Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955 [TBL] [Abstract][Full Text] [Related]
15. A multifunctional platinum(IV) and cyanine dye-based polyprodrug for trimodal imaging-guided chemo-phototherapy. Li S; Wu Y; Liu S; Wu T; Liu G; Li T; Chen Z J Mater Chem B; 2022 Feb; 10(7):1031-1041. PubMed ID: 35080231 [TBL] [Abstract][Full Text] [Related]
16. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug. He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480 [TBL] [Abstract][Full Text] [Related]
17. Photo-controlled targeted intracellular delivery of both nitric oxide and singlet oxygen using a fluorescence-trackable ruthenium nitrosyl functional nanoplatform. Xiang HJ; An L; Tang WW; Yang SP; Liu JG Chem Commun (Camb); 2015 Feb; 51(13):2555-8. PubMed ID: 25567668 [TBL] [Abstract][Full Text] [Related]
18. Tumor cell specific and lysosome-targeted delivery of nitric oxide for enhanced photodynamic therapy triggered by 808 nm near-infrared light. Xiang HJ; Deng Q; An L; Guo M; Yang SP; Liu JG Chem Commun (Camb); 2016 Jan; 52(1):148-51. PubMed ID: 26503188 [TBL] [Abstract][Full Text] [Related]
19. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance. Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044 [TBL] [Abstract][Full Text] [Related]
20. Photoactivatable Prodrug-Backboned Polymeric Nanoparticles for Efficient Light-Controlled Gene Delivery and Synergistic Treatment of Platinum-Resistant Ovarian Cancer. Zhang Q; Kuang G; He S; Lu H; Cheng Y; Zhou D; Huang Y Nano Lett; 2020 May; 20(5):3039-3049. PubMed ID: 32250633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]